SoylentNews

looorg [soylentnews.org] writes:

The FDA has approved a new drug for Alzheimer's disease, while not a cure it is supposed to slow the decline. Even tho data is not entirely positive or straight forward in its interpretation or that it will actually even work as thought.

But if you have it then you are probably desperate enough to try almost anything that claims to work, until you get to the price tag of $56,000 per year. That will probably make it out of reach for most people, it's doubtful if any insurance will cover something like this. Perhaps you can just forget to pay the bill, they might understand due to your condition.

Biogen CEO Michel Vounatsos told ... he thought the drug’s price was "fair" but also vowed that the company would not hike its price for four years.

https://www.cnbc.com/2021/06/07/fda-approves-biogens-alzheimers-drug-the-first-new-therapy-for-the-disease-in-nearly-two-decades.html [cnbc.com]

Original Submission